Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
Robert Sidonio, Professor of Pediatrics at Emory University Hospital, shared a post on LinkedIn:
”It is our great pleasure to share that our publication “Activated Prothrombin Complex Concentrate in Patients Receiving Emicizumab Prophylaxis: From Evidence to Clinical Practice” is now available for free access online as Pre-proof. Thanks to Takeda for organizing this awesome group of hematologists!”
Read the full article here.
In the recently published article ‘Activated Prothrombin Complex Concentrate in Patients Receiving Emicizumab Prophylaxis: From Evidence to Clinical Practice‘ by Robert F. Sidonio Jr. et al., in the RPTH Journal, the role of Activated Prothrombin Complex Concentrate in patients receiving Emicizumab prophyaxis is discussed.
Stay updated on the latest scientific advancements in the filed with Hemostasis Today.
-
Jul 11, 2026, 09:34Heading to ISTH 2026 in Paris Join our session on patient led VTE education – NBCA
-
Jul 11, 2026, 09:33Flora Peyvandi: Empowering the Next Generation of ISTH
-
Jul 11, 2026, 09:28Ruah Alyamany: Surgical and Procedural Bleeding Risk – Perioperative AC guidance
-
Jul 11, 2026, 09:24Habib Bennaceur: New Perspectives on Patient-Centered Hemophilia Care at ISTH 2026
-
Jul 11, 2026, 09:01Nathan Connell: Celebrating 100 Years of von Willebrand Disease at ISTH 2026
-
Jul 11, 2026, 08:50Heghine Khachatryan: Multidisciplinary PERTs Transform Pulmonary Embolism Care
-
Jul 11, 2026, 08:37Alejandro González Veliz: Key Takeaways from the 2026 ACC Scientific Statement on Antiplatelet Therapy
-
Jul 11, 2026, 08:35Rono Chonginio: The Power of Visual Storytelling in Healthcare and Non-Profits
-
Jul 11, 2026, 08:35Mavis Agnes Kisakye: Why Patient Identification Begins with an Informed Community